INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
(NASDAQ: INMB) Delayed: 2.18 +0.13 (6.34%)
Previous Close $2.05    52 Week High $ 
Open $2.07    52 Week Low $ 
Day High $2.22    P/E N/A 
Day Low $2.06    EPS $ 
Volume 421,333       

(NASDAQ: INMB) Delayed: 2.18 +0.13 (6.34%)
Previous Close $2.05    52 Week High $ 
Open $2.07    52 Week Low $ 
Day High $2.22    P/E N/A 
Day Low $2.06    EPS $ 
Volume 421,333